Newsmax Inc. to Announce Q1 Earnings on May 14
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 57 minutes ago
0mins
Should l Buy NMAX?
Source: seekingalpha
- Earnings Announcement Date: Newsmax Inc. is set to release its Q1 2023 earnings report on May 14 after market close, with investors keenly awaiting performance insights to gauge future growth potential.
- EPS Expectations: The consensus EPS estimate stands at -$0.04, reflecting a significant year-over-year improvement of 91.8%, indicating progress in the company's efforts to enhance profitability despite still being in the negative.
- Revenue Forecast: The consensus revenue estimate is $48.92 million, representing an 8.0% year-over-year increase, suggesting that the company is maintaining stable revenue growth amidst market challenges.
- Revision Trends: Over the past three months, there have been no upward revisions for EPS or revenue estimates, with one downward revision each, highlighting analysts' cautious outlook on the company's short-term performance.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy NMAX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on NMAX
Wall Street analysts forecast NMAX stock price to rise
2 Analyst Rating
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 6.540
Low
20.00
Averages
20.50
High
21.00
Current: 6.540
Low
20.00
Averages
20.50
High
21.00
About NMAX
Newsmax, Inc. is a holding company that owns 100% of the interests of its operating company, Newsmax Media, Inc. (Newsmax Media). Newsmax Media is a television broadcaster and multi-platform content publisher. Its Broadcast segment of the Company’s business produces and licenses news, business news and lifestyle content for distribution primarily through multichannel video programming distributors (MVPDs), including cable television systems, direct broadcast satellite operators and telecommunication companies, primarily in the United States. The Digital segment includes online advertising, including online display, email advertising, other online placements and print advertisements, subscriptions, including a collection of specialized health and financial newsletters, Newsmax Magazine and four online membership programs, and e-commerce, through its subsidiaries that sell nutraceuticals and nonfiction books on political, financial and health-related topics.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Newsmax Inc. to Announce Q1 Earnings on May 14
- Earnings Announcement Date: Newsmax Inc. is set to release its Q1 2023 earnings report on May 14 after market close, with investors keenly awaiting performance insights to gauge future growth potential.
- EPS Expectations: The consensus EPS estimate stands at -$0.04, reflecting a significant year-over-year improvement of 91.8%, indicating progress in the company's efforts to enhance profitability despite still being in the negative.
- Revenue Forecast: The consensus revenue estimate is $48.92 million, representing an 8.0% year-over-year increase, suggesting that the company is maintaining stable revenue growth amidst market challenges.
- Revision Trends: Over the past three months, there have been no upward revisions for EPS or revenue estimates, with one downward revision each, highlighting analysts' cautious outlook on the company's short-term performance.
See More
Newsmax Stock Plummets 12.3% Amid Market Volatility
- Stock Volatility: Newsmax's share price fell 12.3% in March, contrasting with a 5.1% decline in the S&P 500 and a 4.8% drop in the Nasdaq Composite, indicating the company's vulnerability amid market turbulence.
- Board Changes Raise Concerns: On March 23, Newsmax appointed Dave Evans to its board and audit committee; while it's uncertain if this triggered the sell-off, investor fears regarding financial reporting and internal controls likely intensified selling pressure.
- Earnings Report Missed Expectations: The company's Q4 earnings report on March 26 revealed revenue of $52.2 million, surpassing Wall Street estimates by approximately $8.2 million, yet a net loss of $3 million did not alleviate valuation concerns, leading to continued stock declines post-report.
- Optimistic Sales Outlook: Newsmax anticipates full-year sales for 2026 between $212 million and $216 million, reflecting an annual growth of about 13%, and expects improved operating profits, suggesting long-term growth potential despite short-term stock pressures.
See More
Newsmax Stock Declines Following Board Appointment and Q4 Report
- Board Appointment Impact: Newsmax's stock declined following the appointment of Dave Evans to the board and audit committee, raising investor concerns about potential issues with financial reporting and internal controls.
- Q4 Earnings Highlights: The company reported Q4 revenue of $52.2 million, exceeding Wall Street estimates by $8.2 million, yet still posted a net loss of $3 million, indicating improved profitability.
- Market Performance Volatility: In March, Newsmax shares fell by 12.3%, contrasting with a 5.1% decline in the S&P 500 and a 4.8% drop in the Nasdaq, highlighting its relative weakness in the market.
- Future Sales Outlook: The company anticipates full-year sales for 2026 to range between $212 million and $216 million, representing an annual growth rate of approximately 13%, suggesting optimism for future growth despite current stock performance challenges.
See More
NEWSMAX STOCK INCREASES 4% FOLLOWING RISE IN Q4 REVENUE
- Company Performance: Newsmax shares increased by 4% following a rise in revenue for the fourth quarter.
- Financial Results: The revenue growth indicates a positive financial performance for the company in the recent quarter.
See More
AstraZeneca's Drug Trial Shows Promising Results
- Drug Trial Success: AstraZeneca's experimental drug tozorakimab significantly reduced flare-ups in chronic obstructive pulmonary disease cases, leading to a 3% stock increase, with full results expected at an upcoming medical meeting, potentially enhancing the company's competitive edge in respiratory medications.
- Travel Platform Upgrade: Tripadvisor's stock rose 3% after Bank of America upgraded its rating from neutral to buy, citing accelerating activist engagement and rising strategic optionality across its portfolio, reflecting market confidence in its future growth prospects.
- Construction Firm Earnings Beat: Argan's stock surged over 10.5% after reporting fourth-quarter earnings of $3.47 per share and revenue of $262.1 million, both exceeding analyst expectations, indicating strong performance in the construction sector that may attract more investor interest.
- Game Development Platform Forecast: Unity Software's stock jumped over 11% after issuing preliminary first-quarter adjusted EBITDA guidance of $130 million to $135 million, surpassing previous guidance of $105 million to $110 million, suggesting ongoing growth potential in the game development industry.
See More
Newsmax Reports 12.6% Revenue Growth in Q4 2025
- Significant Revenue Growth: Newsmax reported total revenues of $52.2 million for Q4 2025, reflecting a 9.6% year-over-year increase and surpassing analysts' expectations of $44 million, which bolstered investor confidence in the company's performance during a non-election year.
- Broadcast Revenue Increase: The company's broadcasting revenues grew 12.6% year-over-year to $42.5 million, driven by affiliate fee revenue growth, increased advertising pricing, and licensing revenue, indicating a robust profitability capacity in a competitive market.
- Strong Financial Position: As of December 31, 2025, Newsmax had $131.3 million in cash and short-term investments, including $20.4 million in cash and $110.9 million in short-term investments, showcasing enhanced financial flexibility following its transition to a public company.
- Optimistic Future Outlook: Newsmax anticipates full-year revenue between $212 million and $216 million for 2026, representing a 13% year-over-year growth, with executives emphasizing a focus on sustainable investments in content, technology, and distribution to support long-term shareholder value.
See More
Newsmax Inc. to Announce Q1 Earnings on May 14
- Earnings Announcement Date: Newsmax Inc. is set to release its Q1 2023 earnings report on May 14 after market close, with investors keenly awaiting performance insights to gauge future growth potential.
- EPS Expectations: The consensus EPS estimate stands at -$0.04, reflecting a significant year-over-year improvement of 91.8%, indicating progress in the company's efforts to enhance profitability despite still being in the negative.
- Revenue Forecast: The consensus revenue estimate is $48.92 million, representing an 8.0% year-over-year increase, suggesting that the company is maintaining stable revenue growth amidst market challenges.
- Revision Trends: Over the past three months, there have been no upward revisions for EPS or revenue estimates, with one downward revision each, highlighting analysts' cautious outlook on the company's short-term performance.
See More
Newsmax Stock Plummets 12.3% Amid Market Volatility
- Stock Volatility: Newsmax's share price fell 12.3% in March, contrasting with a 5.1% decline in the S&P 500 and a 4.8% drop in the Nasdaq Composite, indicating the company's vulnerability amid market turbulence.
- Board Changes Raise Concerns: On March 23, Newsmax appointed Dave Evans to its board and audit committee; while it's uncertain if this triggered the sell-off, investor fears regarding financial reporting and internal controls likely intensified selling pressure.
- Earnings Report Missed Expectations: The company's Q4 earnings report on March 26 revealed revenue of $52.2 million, surpassing Wall Street estimates by approximately $8.2 million, yet a net loss of $3 million did not alleviate valuation concerns, leading to continued stock declines post-report.
- Optimistic Sales Outlook: Newsmax anticipates full-year sales for 2026 between $212 million and $216 million, reflecting an annual growth of about 13%, and expects improved operating profits, suggesting long-term growth potential despite short-term stock pressures.
See More
Newsmax Stock Declines Following Board Appointment and Q4 Report
- Board Appointment Impact: Newsmax's stock declined following the appointment of Dave Evans to the board and audit committee, raising investor concerns about potential issues with financial reporting and internal controls.
- Q4 Earnings Highlights: The company reported Q4 revenue of $52.2 million, exceeding Wall Street estimates by $8.2 million, yet still posted a net loss of $3 million, indicating improved profitability.
- Market Performance Volatility: In March, Newsmax shares fell by 12.3%, contrasting with a 5.1% decline in the S&P 500 and a 4.8% drop in the Nasdaq, highlighting its relative weakness in the market.
- Future Sales Outlook: The company anticipates full-year sales for 2026 to range between $212 million and $216 million, representing an annual growth rate of approximately 13%, suggesting optimism for future growth despite current stock performance challenges.
See More
NEWSMAX STOCK INCREASES 4% FOLLOWING RISE IN Q4 REVENUE
- Company Performance: Newsmax shares increased by 4% following a rise in revenue for the fourth quarter.
- Financial Results: The revenue growth indicates a positive financial performance for the company in the recent quarter.
See More
AstraZeneca's Drug Trial Shows Promising Results
- Drug Trial Success: AstraZeneca's experimental drug tozorakimab significantly reduced flare-ups in chronic obstructive pulmonary disease cases, leading to a 3% stock increase, with full results expected at an upcoming medical meeting, potentially enhancing the company's competitive edge in respiratory medications.
- Travel Platform Upgrade: Tripadvisor's stock rose 3% after Bank of America upgraded its rating from neutral to buy, citing accelerating activist engagement and rising strategic optionality across its portfolio, reflecting market confidence in its future growth prospects.
- Construction Firm Earnings Beat: Argan's stock surged over 10.5% after reporting fourth-quarter earnings of $3.47 per share and revenue of $262.1 million, both exceeding analyst expectations, indicating strong performance in the construction sector that may attract more investor interest.
- Game Development Platform Forecast: Unity Software's stock jumped over 11% after issuing preliminary first-quarter adjusted EBITDA guidance of $130 million to $135 million, surpassing previous guidance of $105 million to $110 million, suggesting ongoing growth potential in the game development industry.
See More
Newsmax Reports 12.6% Revenue Growth in Q4 2025
- Significant Revenue Growth: Newsmax reported total revenues of $52.2 million for Q4 2025, reflecting a 9.6% year-over-year increase and surpassing analysts' expectations of $44 million, which bolstered investor confidence in the company's performance during a non-election year.
- Broadcast Revenue Increase: The company's broadcasting revenues grew 12.6% year-over-year to $42.5 million, driven by affiliate fee revenue growth, increased advertising pricing, and licensing revenue, indicating a robust profitability capacity in a competitive market.
- Strong Financial Position: As of December 31, 2025, Newsmax had $131.3 million in cash and short-term investments, including $20.4 million in cash and $110.9 million in short-term investments, showcasing enhanced financial flexibility following its transition to a public company.
- Optimistic Future Outlook: Newsmax anticipates full-year revenue between $212 million and $216 million for 2026, representing a 13% year-over-year growth, with executives emphasizing a focus on sustainable investments in content, technology, and distribution to support long-term shareholder value.
See More
